June 13, 2020 / 9:25 AM / 24 days ago

BRIEF-Dr. Reddy's Laboratories Enters Into Licensing Agreement With Gilead Sciences For Remdesivir

June 13 (Reuters) - Dr.Reddy’s Laboratories Ltd:

* DR. REDDY’S LABORATORIES ENTERS INTO A LICENSING AGREEMENT WITH GILEAD SCIENCES FOR REMDESIVIR

* DR.REDDY’S - ENTERED NON-EXCLUSIVE LICENSING AGREEMENT WITH GILEAD UNDER WHICH CO CAN REGISTER, MANUFACTURE &SELL GILEAD’S REMDESIVIR DRUG

* DR.REDDY’S LABORATORIES LTD - WILL RECEIVE TECHNOLOGY TRANSFER FROM GILEAD FOR MANUFACTURING OF THIS DRUG

* DR.REDDY’S LABORATORIES LTD - UNDER AGREEMENT DR. REDDY’S CAN REGISTER, MANUFACTURE &SELL GILEAD’S REMDESIVIR IN 127 COUNTRIES INCLUDING INDIA

* DR.REDDY’S LABORATORIES LTD - CO NEED TO DO MANUFACTURING SCALE UP AND OBTAIN REGULATORY APPROVAL FOR MARKETING OF THIS DRUG IN RESPECTIVE COUNTRIES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below